| Events
4th Virtual European
Polymer Conference
12-13 June, 2023
Invited lecture:
Biomedical Applications of Thiomers: New Developments, Relevant Clinical Trials and Advanced Products
Prof. Dr. A. Bernkop-Schnürch
more...
7th European Cyclodextrin
Conference
5-8 September, 2023
Budapest, Hungary
Invited lecture:
Thiolated Cyclodextrins: Mimicking the Workhorses of Our Body
Prof. Dr. A. Bernkop-Schnürch
more...
23rd Symposium ADRITELF
11-13 September, 2023
Trieste, Italy
Invited lecture:
Lipid-based Nanocarriers for Oral peptide Drug Delivery: Hype or Hope?
Prof. Dr. A. Bernkop-Schnürch
more...
|
|
|
|
The Drug Delivery Network
ThioMatrix is specialised on the development of non-invasive drug delivery
systems utilizing its core technologies: the Thiomer Technology and SEDDS Technology. Due to the
great potential of these technologies the efficacy of non-invasively delivered:
- therapeutic peptides
- peptidomimetics
- nucleic
acids such as oligonucleotides, plasmid DNA and siRNA
- class
III drugs according to the biopharmaceutical classification system (BCS)
- drugs
being substrate of efflux pumps such as anticancer drugs
can be tremendously improved. A wide
network of partnerships and collaborations with hospitals, veterinary
institutions, CROs and universities has been established to conduct
preclinical through to clinical development of our delivery products. This
network coupled to our technologies and expertise gives us the edge to
reduce the time to market to develop the optimal delivery systems for your
therapeutic candidates. To learn
more about our drug delivery technologies, please visit the technology section where you
will also find the results of various in
vivo studies demonstrating the advantages of our novel drug delivery
products.
|
|
News
A. Bernkop-Schnürch, CSO ThioMatrix, was honored with the PHOENIX Award 2022
more....
|
|
ThioMatrix Hotline:
+43 512 890046
Mo-Th 9.00-17.00
and Fr 9.00-14.00
Print this page
|
|
|